Discovery of new epigenomics-based biomarkers and the early diagnosis of neurodegenerative diseases
Abstract
Treatment options for many neurodegenerative diseases are limited due to the lack of early diagnostic procedures that allow timely delivery of therapeutic agents to affected neurons prior to cell death. While notable advances have been made in neurodegenerative disease biomarkers, whether or not the biomarkers discovered to date are useful for early diagnosis remains an open question. Additionally, the reliability of these biomarkers has been...
Paper Details
Title
Discovery of new epigenomics-based biomarkers and the early diagnosis of neurodegenerative diseases
Published Date
Aug 1, 2020
Journal
Volume
61
Pages
101069 - 101069
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History